failed trials

brain
Biotech

Merck halts ph. 2 Alzheimer’s trial after underwhelming efficacy

Merck stopped the study after the small molecule MK-1167 “did not meet the necessary efficacy criteria to warrant further investigation."
Darren Incorvaia Jul 1, 2026 2:35pm
Layoffs

Pressure of biopharma layoffs continues to ease in Q2'26

Jul 1, 2026 10:30am
Goal disorientation and lack of vision

Vistagen fails another phase 3 anxiety trial, spies path forward

Jun 30, 2026 9:48am
Goal disorientation and lack of vision

Evommune’s phase 2b flops, ending challenge to Novartis in hives

Jun 29, 2026 10:00am
Wooden blocks with arrow and error icon Delays and disruptions stop the process critical error concept

Soligenix axes lymphoma program after phase 3 setback

Jun 15, 2026 7:53am
Sanofi

Sanofi halts phase 3 autoimmune trial early over lackluster data

Jun 10, 2026 4:25am